SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity.

MLA

Hartmann, Stella, et al. “SARS-CoV-2 ORF3a Drives Dynamic Dense Body Formation for Optimal Viral Infectivity.” Research Square, May 2024. EBSCOhost, https://doi.org/10.21203/rs.3.rs-4292014/v1.

APA

Hartmann, S., Radochonski, L., Ye, C., Martinez-Sobrido, L., & Chen, J. (2024). SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity. Research Square. https://doi.org/10.21203/rs.3.rs-4292014/v1

Chicago

Hartmann, Stella, Lisa Radochonski, Chengjin Ye, Luis Martinez-Sobrido, and Jueqi Chen. 2024. “SARS-CoV-2 ORF3a Drives Dynamic Dense Body Formation for Optimal Viral Infectivity.” Research Square, May. doi:10.21203/rs.3.rs-4292014/v1.